Topic: Eli Lilly

Pharmaceutical company Eli Lilly announced Tuesday that it has agreed to buy gene therapy biotech Prevail for more than $1 billion.

A hospital trial of Eli Lilly's COVID-19 antibody treatment has ended while other trials of the drug continue.

The Dow Jones Industrial Average fell 165 points on Wednesday as Treasury Secretary Steven Mnuchin said it would be difficult to reach a deal on a new COVID-19 stimulus bill before November's election.

U.S. health regulators have paused Eli Lilly's trial of an antibody treatment for COVID-19 over potential safety concerns.

Pharmaceutical company AstraZeneca has reached a $486 million deal with the U.S. government to supply as many as 100,000 doses of its experimental COVID-19 antibody treatment, if it's ultimately approved.

President Donald Trump was briefed on stimulus negotiations and Hurricane Delta in the Oval Office on Wednesday, two days after being discharged from the hospital where he underwent treatment for COVID-19.

Drugmaker Eli Lilly on Wednesday announced it has submitted an emergency authorization request to the U.S. Food and Drug Administration for an experimental COVID-19 antibody treatment.

The United States saw a rise in COVID-19 cases on Tuesday at a level not seen in more than a month, according to updated figures from Johns Hopkins University.

Drugmaker Eli Lilly and Incyte said Monday baricitinib in combination with remdesivir reduced overall recovery time in comparison with just Remdesivir in a COVID-19 treatment trial.

The Nasdaq composite index rose to an all-time high Monday, gaining 1.47% after tech stocks turned in a strong performance led by Microsoft stock rising 5%.